These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1436753)

  • 1. High dose refractoriness to the neuromuscular toxicity of dithiobiuret in rats.
    Williams KD; Peterson RE; Atchison WD
    Neurotoxicology; 1992; 13(2):331-45. PubMed ID: 1436753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of spontaneous and evoked release of acetylcholine during dithiobiuret-induced neuromuscular weakness.
    Atchison WD
    J Pharmacol Exp Ther; 1989 Jun; 249(3):735-43. PubMed ID: 2499675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of dithiobiuret toxicity in rats.
    Williams KD; Lopachin RM; Atchison WD; Peterson RE
    Neurotoxicology; 1986; 7(1):33-49. PubMed ID: 3012425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voltage clamp analysis reveals multiple populations of quanta released at neuromuscular junctions of rats treated with 2,4-dithiobiuret.
    Spitsbergen JM; Atchison WD
    J Pharmacol Exp Ther; 1991 Jan; 256(1):159-63. PubMed ID: 1899115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 2,4-dithiobiuret treatment in rats on cholinergic function and metabolism of the extensor digitorum longus muscle.
    Weiler MH; Williams KD; Peterson RE
    Toxicol Appl Pharmacol; 1986 Jun; 84(2):220-31. PubMed ID: 3087022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphometric characterization of the neuromuscular junction of rodents intoxicated with 2,4-dithiobiuret: evidence that nerve terminal recycling processes contribute to muscle weakness.
    Rheuben MB; Autio DM; Xu YF; Atchison WD
    Toxicol Appl Pharmacol; 2004 Apr; 196(2):266-86. PubMed ID: 15081273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal analysis of dithiobiuret neurotoxicity in rats and assessment of potential nonneural causes.
    Williams KD; Miller MS; Boysen BG; Peterson RE
    Toxicol Appl Pharmacol; 1987 Nov; 91(2):212-21. PubMed ID: 3118511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced safety factor for neuromuscular transmission and abnormal quantal secretion precede neuromuscular weakness induced by dithiobiuret.
    Atchison WD
    Toxicol Appl Pharmacol; 1990 Nov; 106(2):234-44. PubMed ID: 2175053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute alterations in murine neuromuscular transmission following exposure to a nonparalytic dose of dithiobiuret.
    Spitsbergen JM; Atchison WD
    Toxicol Appl Pharmacol; 1990 Jan; 102(1):68-79. PubMed ID: 2153319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment of synaptic vesicle exocytosis and recycling during neuromuscular weakness produced in mice by 2,4-dithiobiuret.
    Xu YF; Autio D; Rheuben MB; Atchison WD
    J Neurophysiol; 2002 Dec; 88(6):3243-58. PubMed ID: 12466444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age dependence of dithiobiuret neurotoxicity in male and female rats.
    Atchison WD; Dickins J; Peterson RE
    Neurotoxicology; 1982 Dec; 3(4):233-41. PubMed ID: 6820684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular mechanisms of atracurium-induced tetanic fade in the isolated rat muscle.
    Nascimento DC; Serra CS; Oliveira AC
    Basic Clin Pharmacol Toxicol; 2004 Jul; 95(1):9-14. PubMed ID: 15245570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The paralytic agent 2,4-dithiobiuret decreases open time of murine skeletal muscle acetylcholine receptor channels.
    Spitsbergen JM; Atchison WD
    J Pharmacol Exp Ther; 1995 Feb; 272(2):645-51. PubMed ID: 7531763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dose and dosing regimen on tissue distribution and elimination kinetics of [14C] dithiobiuret in rats.
    Porter WR; Dickins J; Atchison WD; Peterson RE
    Neurotoxicology; 1983; 4(4):57-68. PubMed ID: 6422353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of 2,4-dithiobiuret on the synthesis and release of acetylcholine and dopamine from rat pheochromocytoma (PC12) cells.
    Ireland LM; Yan CH; Nelson LM; Atchison WD
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1453-62. PubMed ID: 8531116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the paralytic agent 2,4-dithiobiuret on viability and morphology of rat pheochromocytoma (PC12) cells.
    Rheuben MB; Autio DM; Yao AZ; Atchison WD
    Neurotoxicology; 1997; 18(1):105-22. PubMed ID: 9215993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylmercury-induced depression of neuromuscular transmission in the rat.
    Atchison WD; Narahashi T
    Neurotoxicology; 1982 Nov; 3(3):37-50. PubMed ID: 6298679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisatracurium: myographical and electrophysiological studies in the isolated rat muscle.
    Serra CS; Oliveira AC
    Fundam Clin Pharmacol; 2006 Jun; 20(3):291-8. PubMed ID: 16671964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of 2,4-dithiobiuret on sensory and motor function.
    Crofton KM; Dean KF; Hamrick RC; Boyes WK
    Fundam Appl Toxicol; 1991 Apr; 16(3):469-81. PubMed ID: 1906822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.